# Uxin Ltd: Form 20-F for the period ended Mar 31, 2022

- Company: [Uxin Ltd](/companies/uxin.md) (CIK 1729173)
- Form: 20-F
- Filed: 2022-08-01
- Accepted by EDGAR: Aug 1, 2022, 07:02 ET
- Period: 2022-03-31
- Accession: 0000950170-22-013561
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1729173/000095017022013561/uxin-20220331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1729173/000095017022013561/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-04-01 to 2022-03-31 | $258.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2021-04-01 to 2022-03-31 | $250.6m | us-gaap:CostOfRevenue |
| Gross profit | 12 months, 2021-04-01 to 2022-03-31 | $7.5m | us-gaap:GrossProfit |
| Research and development | 12 months, 2021-04-01 to 2022-03-31 | $5.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2021-04-01 to 2022-03-31 | −$44.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2021-04-01 to 2022-03-31 | $6.5m | us-gaap:InterestExpense |
| Income tax | 12 months, 2021-04-01 to 2022-03-31 | $39.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2021-04-01 to 2022-03-31 | −$22.6m | us-gaap:NetIncomeLoss |
| Diluted shares (weighted) | 12 months, 2021-04-01 to 2022-03-31 | 1,354,506,021 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2021-04-01 to 2022-03-31 | −$133.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-04-01 to 2022-03-31 | $2.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-03-31 | $20.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-03-31 | $137.9m | us-gaap:AssetsCurrent |
| Total assets | at 2022-03-31 | $197.4m | us-gaap:Assets |
| Current liabilities | at 2022-03-31 | $204.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-03-31 | $352.5m | us-gaap:Liabilities |
| Long-term debt | at 2022-03-31 | CNY 233.0m | us-gaap:LongTermDebt |
| Current portion of debt | at 2022-03-31 | $36.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2022-03-31 | −$238.2m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1729173/000095017022013561/uxin-20220331.htm

Filed Aug 1, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-013561. Last ingested by Listed: Nov 3, 2026, 09:26 ET. No prices; not investment advice.